A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)
Clinical trial NCT02235740 · TERMINATED
Trial details
- NCT number
- NCT02235740
- Sponsor
- Novartis
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-10-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.